1.000000 0.000000 0.000000 0.000000 1.000000 0.000000 0.000000 0.000000 1.000000 0.00000 0.00000 0.00000 Spyroulias, G.A. Papazacharias, S. Pairas, G. Cordopatis, P. http://mmcif.pdb.org/dictionaries/ascii/mmcif_pdbx.dic 1 90.00 90.00 90.00 1.000 1.000 1.000 C4 H9 N O2 103.120 n ALPHA-AMINOISOBUTYRIC ACID L-peptide linking C3 H7 N O2 89.093 y ALANINE L-peptide linking C6 H15 N4 O2 1 175.209 y ARGININE L-peptide linking C4 H8 N2 O3 132.118 y ASPARAGINE L-peptide linking C4 H7 N O4 133.103 y ASPARTIC ACID L-peptide linking C9 H11 N O2 165.189 D-PHENYLALANINE D-peptide linking C5 H10 N2 O3 146.144 y GLUTAMINE L-peptide linking C5 H9 N O4 147.129 y GLUTAMIC ACID L-peptide linking C6 H10 N3 O2 1 156.162 y HISTIDINE L-peptide linking C6 H13 N O2 131.173 y ISOLEUCINE L-peptide linking C6 H13 N O2 131.173 y LEUCINE L-peptide linking C6 H15 N2 O2 1 147.195 y LYSINE L-peptide linking C5 H11 N O2 S 149.211 y METHIONINE L-peptide linking H2 N 16.023 AMINO GROUP non-polymer C9 H11 N O2 165.189 y PHENYLALANINE L-peptide linking C5 H9 N O2 115.130 y PROLINE L-peptide linking C3 H7 N O3 105.093 y SERINE L-peptide linking C4 H9 N O3 119.119 y THREONINE L-peptide linking C5 H11 N O2 117.146 y VALINE L-peptide linking IX Eur.J.Biochem. EJBCAI 0262 0014-2956 269 6009 10.1046/J.1432-1033.2002.03278.X 12473096 Monitoring the Structural Consequences of Phe12-->D-Phe and Leu15-->Aib Substitution in Human/Rat Corticotropin Releasing Hormone. Implications for Design of Crh Antagonists. 2002 UK Protein Eng. PRENE9 0859 0269-2139 6 149 10.1093/PROTEIN/6.2.149 8386360 Solution Structure of Human Corticotropin Releasing Factor by 1H NMR and Distance Geometry with Restrained Molecular Dynamics. 1993 1.000000 0.000000 0.000000 0.000000 1.000000 0.000000 0.000000 0.000000 1.000000 0.00000 0.00000 0.00000 SYNTHETIC ANALOGUE WITH ISOLEUCINE-AMIDE C-TERMINUS 4734.436 CORTICOTROPIN RELEASING HORMONE YES 1 syn polymer CORTICOLIBERIN no yes SEEPPISLDLT(DPN)HL(AIB)REVLEMARAEQLAQQAHSNRKLMEII(NH2) SEEPPISLDLTFHLAREVLEMARAEQLAQQAHSNRKLMEIIX A polypeptide(L) n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n repository Initial release Database references Derived calculations Other Source and taxonomy Structure summary Version format compliance 1 0 2001-10-31 1 1 2016-12-21 PDBE Y PDBE 2001-10-20 REL SYNTHETIC ANALOGUE SYNTHESIZED THROUGH SOLID PHASE SYNTHESIS USING FMOC/TBU SYNTHETIC PROTOCOLS. NATIVE PHE12 AND LEU15 HAS BEEN SUBSTITUTED BY D-PHE AND ALPHA-AMINOISOBUTYRIC ACID 9606 HUMAN HOMO SAPIENS sample MEAN STRUCTURE. THE STRUCTURE WAS DETERMINED USING 1H-1H DOUBLE-RESONANCE NMR SPECTROSCOPY. NMR-DERRIVED DISTANCE RESTRAINTS AND 3JHAHN COUPLING CONSTANTS AS WELL AS H-BOND CONSTRAINTS USED IN STRUCTURAL CALCULATION AND REFIMENT PROCEEDURE. LEAST RESTRAINT VIOLATION 40 1 COSY TOCSY NOESY 3.8 pH 1 atm 310 K REFINEMENT DETAILS CAN BE FOUND IN THE JRNL CITATION ABOVE. HYBRID DISTANCE GEOMETRY SIMULATED ANNEALING IN TORSION ANGLE SPACE 34% H2O / 66% TFE PETER KOLLMAN, DAVE CASE, KEN MERZ, THOMAS CHEATHAM, CARLOS SIMMERLING, TOM DARDEN refinement AMBER 5.0 structure solution DYANA structure solution AMBER 600 Bruker AMX SER 1 n 1 SER 1 A GLU 2 n 2 GLU 2 A GLU 3 n 3 GLU 3 A PRO 4 n 4 PRO 4 A PRO 5 n 5 PRO 5 A ILE 6 n 6 ILE 6 A SER 7 n 7 SER 7 A LEU 8 n 8 LEU 8 A ASP 9 n 9 ASP 9 A LEU 10 n 10 LEU 10 A THR 11 n 11 THR 11 A DPN 12 n 12 DPN 12 A HIS 13 n 13 HIS 13 A LEU 14 n 14 LEU 14 A AIB 15 n 15 AIB 15 A ARG 16 n 16 ARG 16 A GLU 17 n 17 GLU 17 A VAL 18 n 18 VAL 18 A LEU 19 n 19 LEU 19 A GLU 20 n 20 GLU 20 A MET 21 n 21 MET 21 A ALA 22 n 22 ALA 22 A ARG 23 n 23 ARG 23 A ALA 24 n 24 ALA 24 A GLU 25 n 25 GLU 25 A GLN 26 n 26 GLN 26 A LEU 27 n 27 LEU 27 A ALA 28 n 28 ALA 28 A GLN 29 n 29 GLN 29 A GLN 30 n 30 GLN 30 A ALA 31 n 31 ALA 31 A HIS 32 n 32 HIS 32 A SER 33 n 33 SER 33 A ASN 34 n 34 ASN 34 A ARG 35 n 35 ARG 35 A LYS 36 n 36 LYS 36 A LEU 37 n 37 LEU 37 A MET 38 n 38 MET 38 A GLU 39 n 39 GLU 39 A ILE 40 n 40 ILE 40 A ILE 41 n 41 ILE 41 A NH2 42 n 42 NH2 42 A author_defined_assembly 1 monomeric A AIB 15 ALPHA-AMINOISOBUTYRIC ACID A AIB 15 ALA 1.0000000000 0.0000000000 0.0000000000 0.0000000000 1.0000000000 0.0000000000 0.0000000000 0.0000000000 1.0000000000 1_555 x,y,z identity operation 0.0000000000 0.0000000000 0.0000000000 1 A GLU 17 -96.34 -67.34 CORTICOTROPIN RELEASING HORMONE MINIMIZED AVERAGE Monitoring the structural Consequences of Phe12-->D-Phe12 and Leu15-->Aib15 substitution in h/r Corticotropin Releasing Hormone: Implications for Design of CRH antagonists. 1 N N A ILE 6 A ILE 6 HELX_P A VAL 18 A VAL 18 1 1 13 A GLU 20 A GLU 20 HELX_P A ILE 40 A ILE 40 1 2 21 covale 1.333 A THR 11 A C THR 11 1_555 A DPN 12 A N DPN 12 1_555 covale 1.333 A DPN 12 A C DPN 12 1_555 A HIS 13 A N HIS 13 1_555 covale 1.334 A LEU 14 A C LEU 14 1_555 A AIB 15 A N AIB 15 1_555 covale 1.338 A AIB 15 A C AIB 15 1_555 A ARG 16 A N ARG 16 1_555 covale 1.333 A ILE 41 A C ILE 41 1_555 A NH2 42 A N NH2 42 1_555 HORMONE HORMONE, CORTICOTROPIN RELEASING HORMONE, SYNTHETIC ANALOGUES, SOLID PHASE SYNTHESIS, SOLUTIONS STRUCTURE CRF_HUMAN UNP 1 P06850 154 194 1GO9 1 41 P06850 A 1 1 41 1 PHE engineered mutation DPN 12 1GO9 A P06850 UNP 165 12 1 LEU engineered mutation AIB 15 1GO9 A P06850 UNP 168 15 1 amidation NH2 42 1GO9 A P06850 UNP 42 1 P 1